Grey Owl Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-27,719
Closed -$845K 52
2014
Q1
$845K Buy
27,719
+552
+2% +$16.5K 0.97% 29
2013
Q4
$789K Buy
+27,167
New +$791K 1.04% 29

Other funds holding PFE

Grey Owl Capital Management's PFE Position: Q2 2014 in Review

Grey Owl Capital Management sold out of Pfizer (PFE) in Q2 2014, closing a stake of 27,719 shares — an estimated $845K sold.

Grey Owl Capital Management first reported a position in PFE in Q4 2013 and held it in 2 quarters. The position peaked at $845K in Q1 2014. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Grey Owl Capital Management reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • Grey Owl Capital Management sold 27,719 Pfizer shares in Q2 2014, an estimated $845K.
  • Grey Owl Capital Management first reported a position in Pfizer in Q4 2013 and held it in 2 quarters.
  • Grey Owl Capital Management's Pfizer position peaked at $845K in Q1 2014.
  • 1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Grey Owl Capital Management's 13F filing for Q2 2014, filed 8 Aug 2014.